SRI 31215 TFA
SRI 31215 TFA is a small molecule triplex inhibitor that potently targets matriptase, hepsin, and HGFA, mimicking the function of endogenous HAI-1/2 proteins. It is a valuable research tool for studying HGF/c-Met signaling pathways in cancer metastasis and tissue repair, with applications in both in vitro enzymatic assays and cell-based studies.
Product Specifications
CAS Number
1832686-44-8
Product Name Alternative
SRI31215, SRI-31215, SRI 31215 TFA, HGFR, HGFA, hepsin, matriptase, c-Met/HGFR, cMet/HGFR, c-Met, cMet
Field of Research
Immunology & Inflammation, Signal Transduction
Purity
98.25% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.75 mM) ; DMSO:25 mg/mL (46.85 mM)
Smiles
OC (=O) C (F) (F) F.CC1CN (CC2CCN (Cc3ccccc3) CC2) C (=O) N (C1) c1cccc (c1) C (N) =N
Molecular Formula
C27H34F3N5O3
Molecular Weight
533.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
